Ganesan Vaidyanathan

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Molecular pharmaceutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Bioconjugate chemistry

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Vandana Batra, Minu Samanta, Mehran Makvandi, David Groff, Paul Martorano, Jimmy Elias, Pietro Ranieri, Matthew Tsang, Catherine Hou, Yimei Li, Bruce R Pawel, Daniel Martinez, Ganesan Vaidyanathan, Sean Carlin, Daniel A Pryma, John M Maris
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Yutian Feng, Samantha M Sarrett, Rebecca L Meshaw, Ganesan Vaidyanathan, Mike A Cornejo, Brian M Zeglis, Michael R Zalutsky
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent. Journal of medicinal chemistry 65 (22) (2022)
Zhengyuan Zhou, Nick Devoogdt, Michael R Zalutsky, Ganesan Vaidyanathan
An Efficient Method for Labeling Single Domain Antibody Fragments with 18F Using Tetrazine- Trans-Cyclooctene Ligation and a Renal Brush Border Enzyme-Cleavable Linker. Bioconjugate chemistry 29 (12) (2018)
Zhengyuan Zhou, Darryl McDougald, Nick Devoogdt, Michael R Zalutsky, Ganesan Vaidyanathan
Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6-[18F]Fluoronicotinate Resulting in High Tumor-to-Kidney Ratios. Molecular pharmaceutics 16 (1) (2018)